| Title |
Acute effects of ayahuasca on neuropsychological performance: differences in executive function between experienced and occasional users
|
|---|---|
| Published in |
Psychopharmacology, June 2013
|
| DOI | 10.1007/s00213-013-3167-9 |
| Pubmed ID | |
| Authors |
José Carlos Bouso, Josep Maria Fábregas, Rosa Maria Antonijoan, Antoni Rodríguez-Fornells, Jordi Riba |
| Abstract |
Ayahuasca, a South American psychotropic plant tea containing the psychedelic 5-HT2A receptor agonist N,N-dimethyltryptamine, has been shown to increase regional cerebral blood flow in prefrontal brain regions after acute administration to humans. Despite interactions at this level, neuropsychological studies have not found cognitive deficits in abstinent long-term users. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Norway | 1 | 33% |
| Australia | 1 | 33% |
| Unknown | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 241 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 2 | <1% |
| United States | 1 | <1% |
| Finland | 1 | <1% |
| Unknown | 237 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 42 | 17% |
| Student > Bachelor | 39 | 16% |
| Student > Ph. D. Student | 27 | 11% |
| Researcher | 24 | 10% |
| Student > Doctoral Student | 14 | 6% |
| Other | 31 | 13% |
| Unknown | 64 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Psychology | 57 | 24% |
| Neuroscience | 27 | 11% |
| Agricultural and Biological Sciences | 23 | 10% |
| Medicine and Dentistry | 22 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 14 | 6% |
| Other | 29 | 12% |
| Unknown | 69 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 May 2020.
All research outputs
#3,084,372
of 24,081,774 outputs
Outputs from Psychopharmacology
#770
of 5,460 outputs
Outputs of similar age
#26,234
of 200,479 outputs
Outputs of similar age from Psychopharmacology
#14
of 44 outputs
Altmetric has tracked 24,081,774 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,460 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.1. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 200,479 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 44 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.